MoneyWorks4Me

Lincoln Pharmaceuticals informs about standalone and consolidated financial results

21 Jun 2018 Evaluate

Pursuant to Regulation 33(3)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lincoln Pharmaceuticals has informed that the Company will continue to submit Quarterly /Year to Date Standalone and Consolidated Financial Results for the Financial Year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..